Tango Therapeutics
NASDAQ: TNGXBoston, US · Founded 2020 · Delaware corporation · 4 known investors
Find your way into Tango Therapeutics
709 people in our graph share verified history with the Tango Therapeutics team — schools, employers, funds. One of them is your warm intro.
Ben Robbinsunlockedknows Adam Crystal · together at Massachusetts General Hospital (overlapped)
×4knows the team · via University of Pennsylvania
×2knows the team · via Harvard Medical School
×3knows the team · via Massachusetts General Hospital
knows the team · via Partners HealthCare
knows the team · via Dana-Farber Cancer Institute
Tango Therapeutics develops genetically targeted medicines using synthetic lethality principles to treat specific tumors. The company focuses on expanding access to precision cancer therapies for patients.
Founders & leadership
Tango Therapeutics was founded in 2020 by Alan Huang.
AH
Alan HuanginFounderHe has spent approximately a decade in CAR-T cell therapy drug development, with experience in manufacturing, regulatory compliance, project management, and team leadership.
AC
Adam CrystalinPresident, Research and DevelopmentAdam Crystal is an MD-PhD medical oncologist and biotech executive with drug discovery and development experience in pharma and biotech, specializing in small-molecule oncology therapeutics and novel target identification. He is an Executive Officer at Tango Therapeutics.
DB
Daniella BeckmaninCFO
DB
Douglas BarryNamed on SEC filing
AD
Aaron DavisNamed on SEC filing
Board
BW
KP
Kanishka PothulaBoard directorManaging Partner at Nextech Invest
LA
Lesley Ann CalhouninBoard Member, Audit Committee ChairExecutive Vice President, Chief Operating Officer & Chief Financial Officer at Aligos Therapeutics
AB
Alexis BorisyBoard directorChairman at Nextech Invest
RH
JK
John KetchumBoard director
MP
Malte PetersBoard director
Investors · 4
Reported raises · per SEC filings
Form D private placements$95M disclosed across 2 rounds · 2023–2025
▶$15MraisedOct 2025 · 1 investors · PharmaceuticalsRule 506(b)
▶$15MraisedOct 2025 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John KetchumDirector
- Barbara WeberExecutive Officer, Director
- Malte PetersDirector
- Kanishka PothulaDirector
- Lesley Ann CalhounDirector
- Mace RothenbergDirector
- Alexis BorisyDirector
- Adam CrystalExecutive Officer
- Daniella BeckmanExecutive Officer
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$80MraisedAug 2023 · 17 investors · PharmaceuticalsRule 506(b)
▶$80MraisedAug 2023 · 17 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Lesley Ann CalhounDirector
- Adam CrystalExecutive Officer
- Douglas BarryExecutive Officer
- Mace RothenbergDirector
- Alexis BorisyDirector
- Alan HuangExecutive Officer
- Barbara WeberExecutive Officer, Director
- Daniella BeckmanExecutive Officer
- Malte PetersDirector
- Reid HuberDirector
- Aaron DavisDirector
- Offering amount
- $80M
- Amount sold
- $80M
- First sale
- Aug 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Tango Therapeutics went on to found or lead other companies.
Competitors · 3
by search overlapTango Technology47 shared keywordsTango is a browser extension that automatically captures workflows and turns them into step-by-step how-to guides with screenshots and highlights, which teams can share, embed in knowledge bases, and turn into automations. It targets companies driving digital adoption across web-based tools such as CRM, ERP, and HRIS systems.
Tangoanalytics37 shared keywordsTango Analytics helps businesses manage real estate portfolios through strategic and operational tools.
Tango Tango35 shared keywords
Companies competing with Tango Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Tango Therapeutics do?
- Tango Therapeutics develops genetically targeted medicines using synthetic lethality principles to treat specific tumors. The company focuses on expanding access to precision cancer therapies for patients.
- Who founded Tango Therapeutics?
- Tango Therapeutics was founded by Alan Huang in 2020.
- Who are Tango Therapeutics's investors?
- Tango Therapeutics's investors include Foresite Capital, Nextech Invest, NSG Ventures, Third Rock Ventures.
- How much funding has Tango Therapeutics raised?
- Tango Therapeutics has disclosed $95M raised across 2 rounds.
- Where is Tango Therapeutics headquartered?
- Tango Therapeutics is headquartered in Boston, US.